Empesertib |
Empesertib : Inhibitor of TTK
Probe Summary
Selectivity
Potency
In Vivo
Control Compounds
Chemical Information
References
Vendors
Download
Probe Summary
| Targets | Biochemical/Biophysical Potency | Cellular Potency |
|---|---|---|
| TTK |
|
|
Inhibitor
100 nM
Selectivity
In Vitro Selectivity Assessment
Potency: % inh. - JNK2 54% @ 1 uM, JNK3 84% @ 1 uM
Selectivity Assessment Description:
Empesertib only inhibits two kinases, JNK2 and JNK3, more than 50% at a concentration of 1 μmol/L ...
Potency Cellular
In Vitro
TTK
Mode of Action: Inhibitor
Structure-Activity-Relationship data available? Yes
DOI Reference: 10.1021/acs.jmedchem.9b02035
In Vivo Validations
Mouse, Rat, Dog
Dose: 0.5, 1, 2 mg/Kg
Route of delivery:
Intravenous, Oral
Plasma half life:
4.9 (M), 14 59 (M), (R), 6.3 (D) h IV
Systemic clearance:
0.69 (M), 0.19 (R), 1.4 (D) L/h/Kg IV
DOI Reference: 10.1021/acs.jmedchem.9b02035
Chemical Information
| Molecular Formula | C29H26FN5O4S |
| SMILEs | COc1cc(S(C)(=O)=O)ccc1Nc1nc2ccc(-c3ccc(NC(=O)[C@H](C)c4ccc(F)cc4)cc3)cn2n1 |
| InChI | InChI=1S/C29H26FN5O4S/c1-18(19-4-9-22(30)10-5-19)28(36)31-23-11-6-20(7-12-23)21-8-15-27-33-29(34-35(27)17-21)32-25-14-13-24(40(3,37)38)16-26(25)39-2/h4-18H,1-3H3,(H,31,36)(H,32,34)/t18-/m1/s1 |
| Molecular weight | 559.17 Da |
| AlogP | 5.4333 |
| HBond acceptors | 9 |
| HBond donors | 2 |
| Atoms | 66 |
References
Publications
Vendors
Note: This is not an exhaustive list and does not indicate endorsement by the portal.